A Welwyn-based biotech is looking to raise up to £8 million by the end of the year to advance its product pipeline and take its lead candidate, a treatment for hospital superbug Clostridium difficile - into Phase I clinical trials.
From: www.businessweekly.co.uk
Hertfordshire superbug fighters aiming to raise £8 million
Posted by Ruslan Abuzant at 8:50 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment